Precision BioSciences, Inc.
DTIL
$5.07
$0.112.22%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.26M | 51.14M | 68.70M | 75.10M | 87.64M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.26M | 51.14M | 68.70M | 75.10M | 87.64M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 1.26M | 51.14M | 68.70M | 75.10M | 87.64M |
| SG&A Expenses | 36.52M | 35.93M | 35.68M | 34.57M | 35.43M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 91.37M | 95.23M | 94.86M | 91.30M | 94.93M |
| Operating Income | -90.11M | -44.09M | -26.16M | -16.21M | -7.29M |
| Income Before Tax | -78.26M | -21.99M | 7.17M | 11.48M | 15.79M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -78.26 | -21.99 | 7.17 | 11.48 | 15.79 |
| Earnings from Discontinued Operations | -- | -- | -- | -2.86M | 1.18M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -78.26M | -21.99M | 7.17M | 8.62M | 16.97M |
| EBIT | -90.11M | -44.09M | -26.16M | -16.21M | -7.29M |
| EBITDA | -88.17M | -41.43M | -22.76M | -11.98M | -2.16M |
| EPS Basic | -8.81 | -1.98 | 1.93 | 0.08 | 0.23 |
| Normalized Basic EPS | -5.49 | -1.21 | 1.29 | 0.32 | -0.25 |
| EPS Diluted | -8.82 | -2.02 | 1.89 | 0.05 | 0.20 |
| Normalized Diluted EPS | -5.49 | -1.23 | 1.27 | 0.30 | -0.27 |
| Average Basic Shares Outstanding | 35.63M | 31.55M | 27.31M | 23.16M | 19.71M |
| Average Diluted Shares Outstanding | 35.63M | 31.59M | 27.36M | 23.20M | 19.76M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |